White House Unveils Plan to Combat Emerging Threat of Fentanyl-Laced 'Zombie Drug' Xylazine

Xylazine is an animal tranquilizer increasingly being used to cut fentanyl and other illicit drugs, exacerbating the overdose crisis.
The Biden administration aims to reduce xylazine-involved overdose deaths by 15% in key regions over the next 2-3 years.
The plan focuses on ramping up testing, data collection, prevention, treatment research, and supply chain disruption.
Xylazine does not respond to naloxone, causes dangerous health issues, and currently has no antidote.
Federal agencies will explore regulatory options like scheduling xylazine as a controlled substance.